ConductScience.org, home

Gene · 6012

Papers2,400

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

181 to 200 of 2,400

Download this page as JSON
TitleJournalYearPMIDFound bySource
All-Ferroelectric Spiking Neural Networks via Morphotropic Phase Boundary Neurons.Adv Sci (Weinh)202439382159PubTator, text miningPubMed
Arsenic redox disequilibrium in geogenic contaminated groundwater: Bioenergetic insights from organic molecular characterization and gene-informed modeling.Water Res202439316964PubTator, text miningPubMed
Androgen-type 2 innate lymphoid cells-dendritic cell axis modulates sex-associated differences in skin immune responses.MedComm (2020)202439286780PubTator, text miningPubMed
A case of dermatomyositis with positivity to both anti-MDA5 and anti-ARS antibodies.Eur J Dermatol202439193689PubTator, text miningPubMed
Psychometric evaluation of the Chinese version of the Academic Resilience Scale-30 (C-ARS-30) in college students.Front Psychol202439171240PubTator, text miningPubMed
Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies.Semin Arthritis Rheum202439142036PubTator, text miningPubMed
Transcriptomic profiling and discovery of key transcription factors involved in adventitious roots formation from root cuttings of mulberry.BMC Genomics202439009981PubTator, text miningPubMed
Circularly Polarized Vivaldi Antennas Integrated with Septum-like Polarizer.Sensors (Basel)202439001125PubTator, text miningPubMed
Latrophilins as Downstream Effectors of Androgen Receptors including a Splice Variant, AR-V7, Induce Prostate Cancer Progression.Int J Mol Sci202439000396PubTator, text miningPubMed
Treatment with low-dose nintedanib and tacrolimus in patients with progressive fibrosing interstitial lung diseases with anti-ARS antibody-positive dermatomyositis.Respirol Case Rep202438983609PubTator, text miningPubMed
Clinical importance of anti-Ro52 antibody in polymyositis and dermatomyositis.Mod Rheumatol202438804908PubTator, text miningPubMed
Myositis Autoantibody Profiles and Clinical Significance in Patients with Inflammatory Myopathies in Southwest China.Clin Lab202438747930PubTator, text miningPubMed
Synthetic bacteria designed using ars operons: a promising solution for arsenic biosensing and bioremediation.World J Microbiol Biotechnol202438709285PubTator, text miningPubMed
Early-onset dysphagia and severe neurodevelopmental disorder as early signs in a patient with two novel variants in NARS1: a case report and brief review of the literature.Neurogenetics202438652341PubTator, text miningPubMed
An arresten-derived anti-angiogenic peptide triggers apoptotic cell death in endothelial cells.Mol Biol Rep202438622345PubTator, text miningPubMed
TAS3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer.Mol Oncol202438600681PubTator, text miningPubMed
Gene Duplication of Androgen Receptor As An Evolutionary Driving Force Underlying the Diversity of Sexual Characteristics in Teleost Fishes.Zoolog Sci202438587519PubTator, text miningPubMed
Mechanistic insight into human androgen receptor-mediated endocrine disrupting potential of cyclic depsipeptide mycotoxin, beauvericin, and influencing environmental factors for its biosynthesis in Fusarium oxysporum KFCC 11363P on rice cereal.
Ecotoxicol Environ Saf202438493703PubTator, text miningPubMed
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank.Clin Exp Rheumatol202438488094PubTator, text miningPubMed
Adrenergic receptor system as a pharmacological target in the treatment of epilepsy (Review).Med Int (Lond)202438476984PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/6012/papers?page=10